Archives
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2019-07
- 2019-06
- 2019-05
- 2019-04
- 2018-07
-
Targeting BCL-XL and MCL-1 in Glioblastoma: BH3-Mimetic Insi
2026-07-27
The reference study demonstrates that glioblastoma (GBM) cells—especially the stem-like, therapy-resistant subpopulations—exhibit heightened expression of anti-apoptotic BCL-XL and MCL-1 proteins, creating a therapeutic vulnerability. By sequentially inhibiting these proteins with BH3-mimetic compounds, robust tumor cell apoptosis was achieved in preclinical models, suggesting new avenues for GBM treatment optimization.
-
Oligomycin A in Immunometabolic Macrophage Reprogramming
2026-07-27
Explore the advanced use of Oligomycin A as a mitochondrial ATP synthase inhibitor for precise immunometabolic studies. This article uniquely bridges mitochondrial bioenergetics research with macrophage function, delivering new assay insights and practical guidance.
-
SAR131675: Redefining VEGFR-3 Inhibition in Tumor and Fibros
2026-07-26
Explore the scientific underpinnings of SAR131675, a highly selective VEGFR-3 inhibitor, and its unique role in dissecting lymphangiogenesis and tumor biology. This article delivers an in-depth analysis and practical guidance for advanced research applications.
-
2X Taq PCR Master Mix: Streamlined Genotyping & TA Cloning W
2026-07-25
The 2X Taq PCR Master Mix (with dye) from APExBIO revolutionizes genotyping and cloning workflows by enabling direct gel analysis and reliable TA cloning-ready amplicons. Its optimized reagent formulation simplifies PCR setup, boosts reproducibility, and minimizes errors—making it a go-to choice for high-throughput molecular biology applications.
-
Applied Workflows with (-)-Epigallocatechin Gallate (EGCG)
2026-07-24
Harness (-)-Epigallocatechin gallate (EGCG) as a multifunctional research tool for apoptosis, antiangiogenic, and antiviral assays. This article translates the latest hydrogel microcarrier innovations and troubleshooting wisdom into actionable, reproducible lab workflows—unlocking the full research potential of EGCG from APExBIO.
-
Prostaglandin E2 in Inflammation Research: Applied Workflows
2026-07-24
Prostaglandin E2 (PGE2) is a versatile tool for dissecting immune regulation, inflammation, and mucosal protection in vitro and in vivo. This guide details practical workflows, troubleshooting strategies, and cross-domain insights—empowering researchers to harness high-purity PGE2 from APExBIO for reproducible, high-impact experiments.
-
Extracellular RNA-Protein Complexes in Arabidopsis Apoplast
2026-07-23
Zand Karimi et al. reveal that Arabidopsis apoplastic fluid contains small and circular RNAs predominantly associated with protein complexes outside extracellular vesicles, challenging prior assumptions about RNA packaging. This finding advances understanding of plant extracellular RNA stability and its potential roles in intercellular and cross-kingdom communication.
-
MTT for In Vitro Cell Proliferation: Optimized Workflows & I
2026-07-23
Unlock the full analytical power of MTT (3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyl-2H-tetrazolium bromide) for high-fidelity in vitro cell proliferation and metabolic activity measurement. This guide details advanced protocols, troubleshooting, and translational insights—empowering researchers with APExBIO’s high-purity MTT for robust, reproducible results.
-
Methoxy-X04: Fluorescent Amyloid Beta Probe for Alzheimer’s
2026-07-22
Methoxy-X04 is a validated fluorescent amyloid beta probe enabling high-contrast, rapid visualization of amyloid plaques in Alzheimer’s disease research. Its blood-brain barrier permeability and high affinity for Aβ fibrils (Ki = 26.8 nM) make it a benchmark tool for real-time imaging and quantification of amyloid pathology in vivo and ex vivo.
-
DAPI (4',6-Diamidino-2-Phenylindole) Nuclear Stain Solution
2026-07-22
DAPI (4',6-Diamidino-2-Phenylindole) Nuclear Stain Solution (SKU K2402) provides a robust, ready-to-use method for nuclear visualization in fixed or membrane-compromised cells, streamlining protocols in fluorescence microscopy and flow cytometry. It is not suitable for live-cell imaging due to limited cell permeability, making it critical to match application context for reliable results.
-
BX795 as a PDK1 Inhibitor: Optimizing In Vitro Cancer Assays
2026-07-21
BX795 offers unmatched precision for dissecting PI3K/Akt/mTOR and innate immune signaling in cancer models. This article translates advanced research and practical workflows into actionable protocols, with troubleshooting guidance to maximize the impact of this PDK1 inhibitor in your lab.
-
Methoxy-X04: Advanced Fluorescent Amyloid Beta Probe Workflo
2026-07-21
Methoxy-X04 stands out as a premier brain-permeable fluorescent amyloid beta probe, enabling rapid, high-contrast detection of amyloid pathology in Alzheimer's research models. This article delivers actionable protocol enhancements and troubleshooting strategies to maximize sensitivity and reproducibility, grounded in the latest mechanistic and translational findings.
-
QNZ (EVP4593): Precision Modulation of NF-κB for Fibrosis an
2026-07-20
Explore how QNZ (EVP4593) uniquely enables precise NF-κB pathway modulation in advanced models of infection-driven fibrosis and neurodegeneration. Grounded in recent translational research, this article reveals new applications and critical protocol insights for QNZ.
-
Cefotaxime in Advanced Antimicrobial Resistance Research
2026-07-20
Cefotaxime, a third-generation cephalosporin antibiotic, is indispensable for dissecting resistance mechanisms in both Gram-negative and Gram-positive bacteria. This article details protocol optimizations, troubleshooting strategies, and actionable insights grounded in recent molecular epidemiology, empowering researchers to build robust and translationally relevant infection models.
-
Necrostatin-1: Selective RIP1 Kinase Inhibitor in Necroptosi
2026-07-19
Necrostatin-1, a benchmark RIP1 kinase inhibitor, empowers researchers to dissect necroptosis mechanisms and model inflammatory tissue injury with precision. This guide details experimental workflows, data-driven parameters, and troubleshooting strategies for maximizing reproducibility and specificity using Nec-1 from APExBIO.